Second-Line Treatments in Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Second-Line Treatments in Non-small Cell Lung Cancer

Published:2009-06 Issue:6 Volume:135 Page:1596-1609
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Tassinari Davide,Scarpi Emanuela,Sartori Sergio,Tamburini Emiliano,Santelmo Carlotta,Tombesi Paola,Lazzari-Agli Luigi

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference51 articles.

1. Clinical guidelines for the treatment of unresectable non-small-cell lung cancer: adopted on May 16, 1997 by the American Society of Clinical Oncology;American Society of Clinical Oncology;J Clin Oncol,1997

2. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003;Pfister;J Clin Oncol,2004

3. Prospective randomized trial of docetaxel versus BST in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy;Shepherd;J Clin Oncol,2000

4. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow up;ESMO Guidelines Working Group;Ann Oncol,2007

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress in the therapy of brucellosis;Animal Research and One Health;2023-07-03

2. Synthesizing independent stagewise trials for optimal dynamic treatment regimes;Statistics in Medicine;2020-08-17

3. Systemic Options for Second-Line Therapy and Beyond;IASLC Thoracic Oncology;2018

4. Comparison of the efficacy and tolerability of gefitinib with pemetrexed maintenance after first-line platinum-based doublet chemotherapy in advanced lung adenocarcinoma: single-center experience;OncoTargets and Therapy;2016-10

5. Identifying Subsequent Therapies in Patients with Advanced Non-Small Cell Lung Cancer and Factors Associated with Overall Survival;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2016-09-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3